LINZAGOLIX MAY ADDRESS THE LONG-TERM TREATMENT NEEDS OF WOMEN WITH UTERINE FIBROIDS (UF) WHO HAVE CONTRAINDICATIONS TO HORMONAL ADD-BACK THERAPY (ABT): RESULTS FROM TWO PHASE 3 RANDOMIZED CLINICAL TRIALS

Authors
Category Primary study
JournalFertility and Sterility
Year 2020
This article has no abstract
Epistemonikos ID: 93523eb70fb69702baab16f383498bcce7dfc57b
First added on: Feb 14, 2025